Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daria Mochly-Rosen

Showing results (221-230 of 244) with videos related to

Pageof 25
Sort By:
Nature Communications|April 3, 2024
Author Correction: A selective inhibitor of mitofusin 1-βIIPKC association improves heart failure outcome in ratsJulio C B Ferreira, Juliane C Campos, Nir Qvit, et al.
Scientific Reports|February 11, 2018
Transcriptome analysis and prognosis of ALDH isoforms in human cancerPeter Mu-Hsin Chang, Che-Hong Chen, Chi-Chun Yeh, et al.
Ebiomedicine|June 12, 2025
Corrigendum: Novel and prevalent non-East Asian ALDH2 variants; implications for global susceptibility to aldehydes' toxicity EBioMedicine (2020) - doi: 10.1016/j.ebiom.2020.102753Che-Hong Chen, Julio C B Ferreira, Amit U Joshi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2011
A novel aldehyde dehydrogenase-3 activator leads to adult salivary stem cell enrichment in vivoAlice Banh, Nan Xiao, Hongbin Cao, et al.
Ebiomedicine|May 14, 2020
Novel and prevalent non-East Asian ALDH2 variants; Implications for global susceptibility to aldehydes' toxicityChe-Hong Chen, Julio C B Ferreira, Amit U Joshi, et al.
Nature Chemical Biology|July 5, 2022
Targeting colorectal cancer with small-molecule inhibitors of ALDH1B1Zhiping Feng, Marisa E Hom, Thomas E Bearrood, et al.
Nature Chemical Biology|December 9, 2024
Author Correction: Targeting colorectal cancer with small-molecule inhibitors of ALDH1B1Zhiping Feng, Marisa E Hom, Thomas E Bearrood, et al.
Science (New York, N.Y.)|April 21, 2018
MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2AAgostinho G Rocha, Antonietta Franco, Andrzej M Krezel, et al.
Circulation|September 2, 2016
In Vivo Post-Cardiac Arrest Myocardial Dysfunction Is Supported by Ca2+/Calmodulin-Dependent Protein Kinase II-Mediated Calcium Long-Term Potentiation and Mitigated by Alda-1, an Agonist of Aldehyde Dehydrogenase Type 2Christopher Woods, Ching Shang, Fouad Taghavi, et al.
Nature Immunology|November 28, 2018
Macrophage de novo NAD<sup>+</sup> synthesis specifies immune function in aging and inflammationParas S Minhas, Ling Liu, Peter K Moon, et al.
Pageof 25

Showing results (221-230 of 244) with videos related to

Sort By:
Pageof 25
Nature Communications|April 3, 2024
Author Correction: A selective inhibitor of mitofusin 1-βIIPKC association improves heart failure outcome in ratsJulio C B Ferreira, Juliane C Campos, Nir Qvit, et al.
Scientific Reports|February 11, 2018
Transcriptome analysis and prognosis of ALDH isoforms in human cancerPeter Mu-Hsin Chang, Che-Hong Chen, Chi-Chun Yeh, et al.
Ebiomedicine|June 12, 2025
Corrigendum: Novel and prevalent non-East Asian ALDH2 variants; implications for global susceptibility to aldehydes' toxicity EBioMedicine (2020) - doi: 10.1016/j.ebiom.2020.102753Che-Hong Chen, Julio C B Ferreira, Amit U Joshi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2011
A novel aldehyde dehydrogenase-3 activator leads to adult salivary stem cell enrichment in vivoAlice Banh, Nan Xiao, Hongbin Cao, et al.
Ebiomedicine|May 14, 2020
Novel and prevalent non-East Asian ALDH2 variants; Implications for global susceptibility to aldehydes' toxicityChe-Hong Chen, Julio C B Ferreira, Amit U Joshi, et al.
Nature Chemical Biology|July 5, 2022
Targeting colorectal cancer with small-molecule inhibitors of ALDH1B1Zhiping Feng, Marisa E Hom, Thomas E Bearrood, et al.
Nature Chemical Biology|December 9, 2024
Author Correction: Targeting colorectal cancer with small-molecule inhibitors of ALDH1B1Zhiping Feng, Marisa E Hom, Thomas E Bearrood, et al.
Science (New York, N.Y.)|April 21, 2018
MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2AAgostinho G Rocha, Antonietta Franco, Andrzej M Krezel, et al.
Circulation|September 2, 2016
In Vivo Post-Cardiac Arrest Myocardial Dysfunction Is Supported by Ca2+/Calmodulin-Dependent Protein Kinase II-Mediated Calcium Long-Term Potentiation and Mitigated by Alda-1, an Agonist of Aldehyde Dehydrogenase Type 2Christopher Woods, Ching Shang, Fouad Taghavi, et al.
Nature Immunology|November 28, 2018
Macrophage de novo NAD<sup>+</sup> synthesis specifies immune function in aging and inflammationParas S Minhas, Ling Liu, Peter K Moon, et al.
Pageof 25